Global Head Lice Infestation Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Head Lice Infestation Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. Head lice infestation drug is to kill lice or kill eggs.
Head Lice Infestation Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Head Lice Infestation Drug market is projected to reach US$ 495.6 million in 2034, increasing from US$ 393.8 million in 2022, with the CAGR of 3.3% during the period of 2024 to 2034. Demand from Children and Adult are the major drivers for the industry.
Global Head Lice Infestation Drug key players include Perrigo, Bayer, Prestige Brands, Stada Arzneimittel, Alliance Pharma, etc. Global top five manufacturers hold a share about 35%. Europe is the largest market, with a share about 40%, followed by North America, with a share about 35 percent. In terms of product, Shampoo is the largest segment, with a share about 45%. And in terms of application, the largest application is Children, followed by Adult.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Head Lice Infestation Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bayer
Omega Pharma
Thornton and Ross
Prestige Brands
Perrigo
Actavis
Reckitt Benckier
Tyratech
Shionogi
TecLabs
Arborpharma
Major Pharmaceuticals
Logic Products
Tianren
ParaPRO
Segment by Type
Lotion
Creams
Shampoo
Other
Children
Adult
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Head Lice Infestation Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Head Lice Infestation Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Head Lice Infestation Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Head Lice Infestation Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Head Lice Infestation Drug introduction, etc. Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Head Lice Infestation Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Head Lice Infestation Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Head Lice Infestation Drug market is projected to reach US$ 495.6 million in 2034, increasing from US$ 393.8 million in 2022, with the CAGR of 3.3% during the period of 2024 to 2034. Demand from Children and Adult are the major drivers for the industry.
Global Head Lice Infestation Drug key players include Perrigo, Bayer, Prestige Brands, Stada Arzneimittel, Alliance Pharma, etc. Global top five manufacturers hold a share about 35%. Europe is the largest market, with a share about 40%, followed by North America, with a share about 35 percent. In terms of product, Shampoo is the largest segment, with a share about 45%. And in terms of application, the largest application is Children, followed by Adult.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Head Lice Infestation Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bayer
Omega Pharma
Thornton and Ross
Prestige Brands
Perrigo
Actavis
Reckitt Benckier
Tyratech
Shionogi
TecLabs
Arborpharma
Major Pharmaceuticals
Logic Products
Tianren
ParaPRO
Segment by Type
Lotion
Creams
Shampoo
Other
Segment by Application
Children
Adult
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Head Lice Infestation Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Head Lice Infestation Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Head Lice Infestation Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Head Lice Infestation Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Head Lice Infestation Drug introduction, etc. Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Head Lice Infestation Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.